KELLY MONTOYA: Open Payments
NPI 1396105433 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 16 payments from 9 companies in 2025. Trend: 2023 $381 · 2024 $210 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $141 |
| Janssen Biotech, Inc. | 1 | $35 |
| Novo Nordisk Inc | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Exact Sciences Corporation | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: MOUNJARO, KISUNLA, RYBREVANT, Wegovy, CAPVAXIVE, Cologuard Collection Kit, UNITHROID, QULIPTA.
Industry payments across TX — which companies pay providers there.
